Pathologic concordance between prostate biopsy and radical prostatectomy improves with use of a novel robotic-assisted transperineal fusion biopsy platform. Optimization of risk stratification at prostate biopsy has implications for focal therapy use. www.renalandurologynews.com/news/prostat...

Most men with post-procedural stress urinary incontinence in a prospective study achieved at least halving of pad use within 12 months. www.renalandurologynews.com/news/artific...

In a randomized trial of men with a single suspicious lesion on MRI, targeted perilesional biopsy matched standard targeted and systematic biopsy for detecting clinically significant prostate cancer -- with fewer complications. www.renalandurologynews.com/news/prostat... #prostatecancer

The American Urological Association (AUA) has issued a new guideline on the surgical management of kidney and ureteral stones in a 3-part series published in The Journal of Urology. Read our latest feature: www.renalandurologynews.com/features/aua...

Based on EMBARK data, both enzalutamide monotherapy and combination therapy (with leuprolide) reduced the likelihood of distant metastasis in patients with high-risk biochemically recurrent prostate cancer. www.renalandurologynews.com/news/high-ri... #prostatecancer

The PLCO model may improve prediction of prostate cancer death at the point of screening. The Stockholm3 test may improve screening itself. www.renalandurologynews.com/news/prostat... #prostatecancer

Discomfort with death relates to a number of challenging situations and resulting ethical dilemmas, some of which may originate from unspoken or inadequately articulated goals of care. Read our latest feature: www.renalandurologynews.com/features/end...

In a randomized trial, FANS f-URS and mini-PCNL had comparable immediate stone clearance rates. www.renalandurologynews.com/news/kidney-... #kidneystones

Cribriform carcinoma and/or intraductal carcinoma on prostate histopathology was associated with higher rates of metastasis. www.renalandurologynews.com/news/cribrif... #prostatecancer

While patients with multiple risk factors for kidney stones may receive broad, generalized advice, preventing recurrence requires precision and an individualized plan. Read our latest feature: www.renalandurologynews.com/features/rec... #kidneystones

Patients with CKD are among those at increased risk for West Nile neuroinvasive disease and have nearly twice the risk of dying from the disease. www.renalandurologynews.com/news/chronic... #kidneydisease

Persistent hematuria in patients diagnosed with lupus nephritis independently predicts adverse outcomes. www.renalandurologynews.com/news/hematur... #lupus

Multimodal treatment including radical prostatectomy might lead to improved survival in patients with oligometastatic prostate cancer treated with ADT. www.renalandurologynews.com/reports/pros... #SUO2025 #prostatecancer

Among real-world US patients with mCSPC, apalutamide users achieved PSA90 response approximately 5 months earlier than abiraterone users, with more achieving deeper PSA decline. www.renalandurologynews.com/reports/psa-... #SUO2025 #prostatecancer

Overall survival is no better for patients diagnosed with NMIBC who progress directly to metastasis. www.renalandurologynews.com/reports/non-... #SUO2025 #bladdercancer

Cytoreductive nephrectomy merits further consideration in appropriately risk-stratified, surgically fit patients with mRCC. www.renalandurologynews.com/reports/cyto... #SUO2025 #kidneycancer

A combined PSMA-PET/MRI scanner better detected clinically significant prostate cancer in men on active surveillance. www.renalandurologynews.com/reports/pros... #SUO2025 #prostatecancer

Increases in variant histology bladder cancer in the US highlight the importance of precision in pathologic review of biopsy specimens. www.renalandurologynews.com/reports/vari... #SUO2025 #bladdercancer

Results from phase 2 CORE-008 CIS cohort with high-risk BCG-naïve NMIBC show an 83.7% complete response rate and favorable safety with cretostimogene. www.renalandurologynews.com/reports/cret... #SUO2025 #bladdercancer

What clinicians need to know about ASN’s guidance on potassium, phosphorus additives. Read our latest feature: www.renalandurologynews.com/features/asn... #kidneydisease

Belimumab showed efficacy in a subgroup of patients with lupus nephritis treated with MMF as standard of care background therapy. www.renalandurologynews.com/news/mycophe... #lupus

Patients with Crohn disease may have greater risk of radical prostatectomy complications than those with ulcerative colitis. www.renalandurologynews.com/news/prostat... #prostatecancer

The optimal time to measure PSA response to treatment is 9 months for patients with mHSPC to gauge risk for disease progression. www.renalandurologynews.com/news/prostat... #prostatecancer

The optimal time to measure PSA response to treatment is 9 months for patients with mHSPC to gauge risk for disease progression. www.renalandurologynews.com/news/prostat... #prostatecancer

Patients with UTUC and stone history are at high risk for poor survival outcomes and should be offered adjuvant therapy. www.renalandurologynews.com/news/surviva... #kidneystones

A 45-year-old woman with stage 5 chronic kidney disease due to lupus nephritis visits the nephrology clinic for routine follow-up. Solve our latest clinical quiz: www.renalandurologynews.com/news/nephrol... #kidneydisease

The REMODEL study clarified which pathways are responsible for semaglutide’s cardiorenal effects in patients with CKD and type 2 diabetes. www.renalandurologynews.com/reports/inve... #KidneyWk #KidneyCare

The REMODEL study clarified which pathways are responsible for semaglutide’s cardiorenal effects in patients with CKD and type 2 diabetes. www.renalandurologynews.com/reports/chro... #KidneyCare #KidneyWk

An analysis of kidney biopsies before and after obinutuzumab treatment of lupus nephritis showed histologic remission or near remission in a greater proportion of patients than had complete renal response in the REGENCY trial. www.renalandurologynews.com/reports/lupu... #KidneyWk #KidneyCare

A phase 2 trial shows rilparencel improves annual eGFR slope, which suggests the cell therapy may preserve kidney function in patients with diabetic nephropathy. www.renalandurologynews.com/reports/chro... #KidneyWk #KidneyCare

For decades, the “renal diet” has been a standard part of chronic kidney disease (CKD) management. But as the science of nutrition and nephrology has evolved, an important question has emerged: does the traditional renal diet still make sense? www.renalandurologynews.com/features/ren...

Telitacicept shows efficacy and tolerability over 39 weeks in part A of a phase 3 study in patients with IgA nephropathy. www.renalandurologynews.com/reports/teli... #KidneyWk #KidneyCare

A investigator reported that sibeprenlimab halved baseline proteinuria levels over 12 months in trial patients with IgA nephropathy. www.renalandurologynews.com/reports/sibe... #KidneyWk #KidneyCare

Interim phase 3 trial data show that atacicept reduces proteinuria over 36 weeks in patients with IgA nephropathy. www.renalandurologynews.com/reports/atac... #KidneyWk #KidneyCare

The FINE-ONE phase 3 trial met its primary end point with finerenone significantly reducing albuminuria over 6 months in patients with type 1 diabetes and CKD compared with placebo, on top of standard of care therapy. www.renalandurologynews.com/reports/chro... #KidneyWk #KidneyCare

Lupus nephritis and antiphospholipid antibody are tied with worse SLE mortality, but achieving complete response quicky is associated with better prognosis. www.renalandurologynews.com/news/lupus-n... #lupus

3D augmented reality-assisted imaging during RARP enabled precise identification and removal of tumor lesions at the level of preserved neurovascular bundles, which may reduce positive surgical margins. www.renalandurologynews.com/news/prostat... #prostatecancer

Lupus nephritis treatment duration and regimens reflect dynamic patient needs. www.renalandurologynews.com/news/lupus-n... #lupus

In a large, real-world study, belimumab vs MMF use was associated with decreased odds of kidney failure outcomes, supporting its potential to slow progression. www.renalandurologynews.com/news/belimum... #lupus

ASN’s Kidney Week 2025 promises a robust program: Plenary sessions, key lectures, late-breaking trial data, oral presentations, educational sessions, and more. Read about what to look forward to at #KidneyWk: www.renalandurologynews.com/reports/asn-...

A phase 3 trial supports durvalumab added to BCG induction and maintenance therapy as a potential new treatment for BCG-naïve, high-risk NMIBC. www.renalandurologynews.com/news/bladder... #bladdercancer

The combination of PD-L1 and CTLA-4 inhibition improves disease-free survival after surgery in patients with primary renal cell carcinoma, a phase 3 trial finds. www.renalandurologynews.com/news/renal-c... #kidneycancer

A combination of belzutifan, pembrolizumab, and lenvatinib showed encouraging results as first-line treatment for advanced RCC in an early phase trial. Phase 3 trial data are pending. www.renalandurologynews.com/news/triplet... #kidneycancer

GLP-1 RAs are not linked to increased risks for most serious GI or hepatobiliary outcomes compared with oral diabetes medications. www.renalandurologynews.com/news/glp1ras... #diabetes

Based on IIEF scores, mMicro-energy treatments appear to have long-lasting therapeutic effect in men with erectile dysfunction. www.renalandurologynews.com/news/micro-e...

Low-dose pyridostigmine is an effective treatment for men with underactive bladder who undergo TURP for BPH with BOO, trial findings suggest. www.renalandurologynews.com/news/pyridos...

Extended dissection did not improve recurrence-free or overall survival, but it may have a bladder cancer-specific survival benefit possibly because it removes micrometastases. www.renalandurologynews.com/news/extende...

The transmission electron microscopy (TEM)-based artificial intelligence tool is the first clinically applicable AI system for the diagnosis and quantitative analysis of glomerular diseases. www.renalandurologynews.com/news/ai-syst... #kidneydisease

Patients who undergo single-port robotic prostate or kidney surgery tend to have less blood loss and postoperative pain and shorter hospital stays compared with patients undergoing multi-port robotic surgery. www.renalandurologynews.com/news/single-... #surgery

Long-term data from a prospective phase 2 trial show neoadjuvant cisplatin-based chemotherapy before nephroureterectomy provides durable survival benefits in high-risk, nonmetastatic UTUC. www.renalandurologynews.com/news/urothel... #bladdercancer